Resultados: 545

    Point-of-care tests for urinary tract infections to improve antimicrobial prescribing: early value assessment

    Early value assessment (EVA) guidance on point-of-care tests for urinary tract infections to improve antimicrobial prescribing. Guidance development process Early value assessment (EVA) guidance rapidly provides recommendations on promising health technologies that have the potential to address national...

    Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer

    Evidence-based recommendations on pembrolizumab (Keytruda) plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer in adults....

    Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal)

    NICE is unable to make a recommendation on capmatinib (Tabrecta) for treating advanced non-small-cell lung cancer with MET exon 14 skipping in adults. This is because Novartis Pharmaceuticals did not provide an evidence submission. We will review this decision if the company decides to make a submission....

    Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma

    People with relapsed or refractory diffuse large B-cell lymphoma who cannot have an autologous stem cell transplant usually have polatuzumab vedotin plus rituximab and bendamustine. The clinical evidence is from a small study that did not directly compare tafasitamab plus lenalidomide with any other trea...

    Lapse tervise jälgimise juhend (ajakohastatud)

    In a small country, every person and their potential contribution to society is extremely important. The degree to which the welfare of children and families is invested will sooner or later be reflected in the health of the population, education, crime, employment and the economy. Healthy children can g...

    CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment

    Overview Early value assessment (EVA) guidance on CaRi-Heart for predicting cardiac risk in suspected coronary artery disease. Guidance development process Early value assessment (EVA) guidance rapidly provides recommendations on promising health technologies that have the potential to address national ...

    Semaglutide for managing overweight and obesity

    Evidence-based recommendations on semaglutide (Wegovy) for managing overweight and obesity in adults. Commercial availability The Wegovy brand of semaglutide is not commercially available yet....

    Percutaneous transluminal renal sympathetic denervation for resistant hypertension

    Evidence-based recommendations on percutaneous transluminal renal sympathetic denervation for resistant hypertension. This involves inserting a device through the skin (percutaneous) into an artery in the thigh and then into the renal arteries (transluminal). It sends radio or sound waves to destroy the ...